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Background: In this study, the prevalence and distribution of dental caries and oral hygiene conditions in a group 
of patients with β-TM are evaluated and the results compared to age-and gender-matched healthy patients. In ad-
dition, oral candida colonization and the density of Streptococcus mutans (S.mutans) and Lactobacilli in the total 
saliva are assessed.
Material and Methods: This study involved 59 β-TM patients between 6-16 years old (mean:11.59±3.22), who 
applied to the Department of Pedodontics, Faculty of Dentistry, Akdeniz University, with ongoing follow-up, 
treatment and regular blood transfusions. All enrolled patients were diagnosed with β-TM by the Department 
of Pediatric Hematology and Oncology, Faculty of Medicine, Akdeniz University. As a control group, age-and 
gender-matched healthy 50 patients were included to the study.
Results: Plaque (p=0.001), DMFT (p=0.009) and DMFS (p=0.039) indices were significantly higher in the β-TM 
patients, whereas, the oral hygiene status was significantly lower (p=0.004). Saliva buffering capacity average was 
insignificantly but slightly more in β-TM patients(p=0.131).
While S.mutans values were significantly higher in the β-TM patients (p=0.002), no significant difference was 
found in the Lactobacillus (p=0.131) and Candida values (p=0.33). 
Conclusions: DMFT, DMFS, Plaque and oral hygiene indices and S.mutans values were found significantly differ-
ent in β-TM patients than healthy, control group patients, in this study.   
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Introduction
Hemoglobin is the oxygen-transport protein in the red 
blood cells. Hemoglobin A is the major hemoglobin, 
comprising about 97% of the total hemoglobin. The 
structure of hemoglobin A typically consists of two al-
pha (α) and two beta (β) globin chains (1,2). The thalas-
semias are a group of genetic disorders characterized 
by decreased or absent production of globin chains, 
leading to microcytic anemia. The thalassemias are 
categorized according to the defective globin chain: 
α-thalassemia and β-thalassemia. β-thalassemia is the 
most common genetic disorder worldwide (1-3), and is 
widespread in the Mediterranean countries, the Middle 
East, Central Asia, India, South China, the Far East, and 
on the northern coasts of Africa and South America. 
β-thalassemia is divided into three groups; thalassemia 
minor, thalassemia intermedia and thalassemia major 
(TM). Thalassemia minor is the carrier form of the dis-
ease, and carriers have asymptomatic mild-to-moderate 
microcytic anemia. Thalassemia intermedia patients 
present less severe clinical features than TM patients (1-
3), and do not need regular blood transfusions, as they 
usually have hemoglobin levels of 7–10 g/dl (4). β-TM 
is also known as Cooley anemia or Mediterranean ane-
mia. Patients with β-TM have severe microcytic hypo-
chromic anemia, due to the reduced or absent produc-
tion of β-globin chains, requiring repeated erythrocyte 
transfusions (2-4).
Children born with β-TM only show symptoms during 
the first year of life when adult hemoglobin has replaced 
fetal hemoglobin (5-8). Peripheral anemia arising from 
the disease sends signals to the bone marrow to increase 
the production of red blood cells, but the production of 
red blood cells is abnormal. With time, the marrow 
cavities expand (e.g., skull bones, facial bones, ribs), 
leading to characteristic facial features (referred to as 
“chipmunk” facies or “rodent-faced”) and radiographic 
findings. If the disease is not treated, death can occur 
from anemia and congestive heart failure. The proper 
treatment for these patients includes routine blood 
transfusions and other therapies to survive (5-8).
The most common oro-facial features among thalassemia 
patients, because of intense compensatory hyperplasia of 
the marrow and expansion of the marrow cavity, are skel-
etal malocclusion, maxillary protrusion, mandibular at-
rophy, increased overjet, anterior open bite, prominence 
of the malar eminence, flat nose, lateral displacement of 
orbits and frontal bossing (5-8). Other dental features 
include flaring and spacing between maxillary incisors, 
cuspidal short roots, taurodontism, attenuated lamina 
dura and thin mandibular cortex (5-8). Additionally, thal-
assemic patients may have other oral symptoms, such as 
dental caries, due to the neglect of oral hygiene but also 
because of the decreasing concentrations of phosphorous 
and immunoglobulin A (Ig A) in saliva (5,6,8-15).
TM is one of the most common genetic disorders caus-
ing public health concern worldwide, including the 
Mediterranean region of Turkey. Nonetheless, a review 
of the literature demonstrates a lack of comprehensive 
studies regarding oro-facial features, dental caries and 
oral hygiene conditions of patients with TM.
In this study, the prevalence and distribution of dental 
caries and oral hygiene conditions in a group of patients 
with β-TM are evaluated and the results compared to 
age- and gender-matched healthy patients. In addition, 
oral Candida colonization and the density of Strepto-
coccus mutans (S. mutans) and Lactobacilli in the total 
saliva are assessed.  
Material and Methods
This study was supported by Akdeniz University, The 
Scientific Research Projects Coordination Unit, under 
the Project No: 2014.01.0151.002.
This case-control study involved 59 β-TM patients be-
tween 6 and 16 years old, who applied to the Depart-
ment of Pedodontics, Faculty of Dentistry, Akdeniz 
University, with ongoing follow-up, treatment and 
regular blood transfusions. All enrolled patients were 
diagnosed with β-TM by the Department of Pediatric 
Hematology/Oncology, Faculty of Medicine, Akdeniz 
University and had no systemic diseases, except TM. 
Patients who used antibiotics or anti-fungal medicines 
within the last 3 months and having splenectomy his-
tory, were excluded. As a control group, 50 patients be-
tween 6 and 16 years old, without any systemic disease, 
who applied to our clinics for routine dental treatments 
and did not use antibiotics and/or anti-fungal medicines 
within the last 3 months, were included. None of the 
patients enrolled in the study and control groups were 
smokers. Patients and parents were informed, and their 
written approvals were taken. Evaluations were carried 
out in the morning before any dental treatment was ap-
plied.
The Akdeniz University Research Ethics Committee 
approved the study (decision dated 12.02.2014 and num-
bered 113).
- Evaluation of Oral Hygiene 
Oral hygiene (debris, calculus) status of the patients in 
the study and control groups was evaluated by the Sim-
plified Oral Hygiene Index (16), which has two compo-
nents: The Debris Index and the Calculus Index. Each 
of these indices is based on numerical determinations, 
representing the amount of debris or calculus found on 
the preselected tooth surfaces (16).
Plaque test (CRT Plaque Test, Ivoclar Vivadent, Liech-
tenstein) solution (a fluorescent disclosing liquid for the 
exposure of plaque) was used to evaluate the patients’ 
plaque index, according to Silness and Löe (17). 
A standard CRT buffer kit (CRT Buffer, Ivoclar Viva-
dent, Liechtenstein) was used to determine the saliva 
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Fig. 1: Distribution of β-TM and control group patients according to 
gender and dentition.
buffering capacity of the patient, by means of a test 
strip featuring a specific indicator system [yellow/
brown: pH<4.0 (low), green: pH<4.5-5.5 (medium), 
blue: pH>6.0 (high)].
The tooth-level indices (DMFT/dft) and surface-level 
indices (DMFS/dfs) were calculated. The DMFT and 
DMFS indices are applied to the permanent dentition 
and are expressed as the total number of teeth or surfac-
es that are decayed (D), missing (M) or filled (F), in an 
individual, respectively. When written in lowercase let-
ters, the dft and dfs indices are a variation that is applied 
to the primary dentition. Missing primary teeth should 
be ignored, because of the difficulty in distinguishing 
between teeth extracted due to caries and those that 
have naturally exfoliated.
- Microbiological Evaluation 
In the morning, saliva samples stimulated with par-
affin gum were collected from patients in the study 
and control groups, for microbiological evaluation. 
The patients were not allowed to eat or drink any-
thing, chew any chewing gums, smoke, brush their 
teeth and use any mouthwashes, at least 1 hour be-
fore the test was conducted. Saliva samples, placed in 
sterile boxes, were homogeneously spread onto test 
kits (CRT Bacteria Refill, Ivoclar Vivadent, Liech-
tenstein) that have a selective medium for S. mutans 
and Lactobacillus on the respective sides. After in-
cubation at 37°C for 48 hours, S. mutans and Lacto-
bacillus were enumerated, according to the manufac-
turer’s instructions.
- Evaluation of Candidal Colonization 
Swab samples, which were taken with an applicator 
from the throat and cheek mucosa of study and control 
groups, were cultivated on a specific media with a loop 
(BD Sabouraud agar, including gentamicin and chlor-
amphenicol), and incubated at 37°C for 24–28 hours. 
Samples were taken from single colonies in the medium 
with a loop, and examined under a light microscope, by 
diluting with serum. Samples that were diagnosed with 
Candida were subcultured onto corn meal agar, Sab-
ouraud dextrose agar and CHROMagar media. Candida 
spices were defined by API 20C AUX kits (BioMérieux, 
Marcy l’Etoile, France).
- Statistical Evaluation
Quantitative variables among the groups were compared 
using the Student’s t-test, for parametric data. Nonpara-
metric data were analyzed by the Kruskal–Wallis and 
Mann-Whitney U tests. Qualitative variables were ex-
amined with the Kruskal–Wallis, Mann-Whitney U, 
chi-square and exact Fisher tests, respectively. Statisti-
cal significance was assumed at p<0.05. All calculations 
were performed using SPSS 15.0 (SPSS Inc., Chicago, 
IL, USA).
Results
The study group consisted of 59 β-TM patients (36 girls, 
23 boys) aged between 6 and 16-years (mean: 11.59±3.22 
years). The control group consisted of 50 patients, whose 
ages were the same range as those in the study group 
(mean: 11.06±2.86 years). The study and control groups 
were divided into subgroups, according to permanent 
and mixed dentition periods, for evaluation.
In β-TM patients, the 21 patients in the mixed dentition 
subgroup were aged between 6 and 11 years (average: 
8.04±1.71 years) while the 38 patients in the permanent 
dentition subgroup were aged between 10 and 16 years 
(mean:13.55±1.91 years) (Fig. 1). In the control group, 
the 25 patients in the mixed dentition subgroup were 
aged 6–9 years (average: 7.4±1.04 years) while the 25 
patients in the permanent dentition subgroup were 12–
16 years old (mean: 12.72±0.93 years) (Fig. 1).
- Evaluation of Oral Hygiene 
The DMFT, DMFS, dft and dfs ratios obtained from the 
β-TM and control group patients (and from subgroups, 
mixed and permanent dentition) have been summarized 
in Table 1, and the oral hygiene statuses, plaque indi-
ces and saliva buffering capacities have been summa-
rized in Table 2. In comparison to the control group, 
the plaque, DMFT and DMFS indices were significant-
ly higher in the β-TM patients (plaque index: p=0.001; 
DMFT index: p=0.009; DMFS p=0.039) (Table 1), 
whereas, the oral hygiene status was significantly lower 
in β-TM (oral hygiene index: p=0.004). Although the 
saliva buffering capacity average was slightly more in 
β-TM patients than the control group, the difference 
was not significant (saliva buffering capacity: p=0.131) 
(Table 2).
When gender differences in the β-TM patients and con-
trol group were considered, only the plaque indices of 
male β-TM patients were found to be higher (p=0.002). 
No significant relationship was found in other param-
eters (p>0.05) (Table 2).
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- Mixed Dentition
A significant difference was only observed in the oral 
hygiene index, among the parameters examined during 
the mixed dentition period. The oral hygiene index was 
lower in β-TM patients than control group patients (oral 
hygiene index: p=0.047) (Table 2).
- Permanent Dentition 
Plaque index, oral hygiene index and DMFT index values 
were shown to be significantly higher in β-TM patients 
than the control group, during the permanent dentition 
period (DMFT index: p=0.014; plaque index: p=0.005; 
oral hygiene index: p=0.023). There was no significant dif-
ference in the DMFS index and saliva buffering capacity 
between the β-TM and control patients (DMFS: p=0.058; 
saliva buffering capacity: p=0.567) (Table 1, Table 2).
- Microbiological Evaluation 
S. mutans and Lactobacillus values obtained from 
β-TM and control group patients (and from subgroups, 
mixed and permanent dentition) have been summarized 
in Table 3. While S. mutans values were significantly 
higher in the β-TM patients than the control group (S. 
mutans: p=0.002), no significant difference was found 
in the Lactobacillus values between these two groups 
(Lactobacillus: p=0.131) (Table 3). A statistically sig-
nificant effect of gender was not evident (p>0.05).
- Mixed Dentition
No significant relationship was seen in the S. mutans 
and Lactobacillus values between the two groups dur-
ing the mixed dentition period (S. mutans: p=0.86; Lac-
tobacillus: p=0.418) (Table 3).
- Permanent Dentition
S. mutans values were statistically higher in β-TM pa-
tients in the permanent dentition period when compared 
to the control group (p=0.008). No significant differ-
ence in Lactobacillus values appeared between the two 
groups (Lactobacillus: p= 0.507) (Table 3).
Table 1: The results of DMFT, DMFS, dft, and dfs indexes.
DMFT DMFS dft dfs


















±4.89 - - - - - -
Total 0 11 3.77±2.79 0 27
4.94


















±3.26 - - - - - -
Total 0 8 2.46±2.26 0 14
3.3
±3.58 - - - - - -
(DMFT; p=0.009, DMFS; p=0.039, Mixed Dentition; p>0.05, Permanent Dentition DMFT; p=0.014, DMFS; p>0.05)
Table 2: The results of Plaque Index, Oral Hygiene Index and Saliva Buffering Capacity.



































































































































(Plaque Index; p=0.001, Mixed Dentition; p>0.05, Permanent Dentition; p=0.005)
(Oral Hygiene Index; p=0.004, Mixed Dentition; p=0.047, Permanent Dentition; p=0.023)
(Saliva Buffering Capacity; p>0.05, Mixed Dentition; p>0.05, Permanent Dentition; p>0.05)
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- Evaluation of Candidal Colonization 
Although, it was not observed in 44 of the β-TM patients 
(74.6%), Candida was seen only in 15 patients. After 
the typing process, Candida albicans was detected in 
14 patients (23.7%), and Candida glabrata was identi-
fied in 1 patient (1.7%). In the control group, Candida 
occurred in 33 out of the 50 patients (66%). Candida 
albicans was found in 16 of these patients and Candida 
parapsilosis in 1 patient, following the typing process.
There was no significant correlation in the Candida 
values between the study and control groups (p=0.33). 
Given the low Candida evaluation rate of patients in the 
study and control groups, the patients in the subgroups 
(mixed and permanent dentition) were not evaluated. 
Discussion
Oral and dental problems and their treatments affect the 
general health of the human body. Especially in people 
with systemic problems, oral and dental issues must be 
evaluated, and certain procedures must be carefully fol-
lowed for treatment. The oral hygiene status must be 
examined, and decay activities of the patients must be 
defined in at-risk patients, such as TM patients.
A limited number of studies are currently available on 
the oral and dental problems of TM patients. Whereas 
some of the studies asserted that the decay frequency 
of TM patients was higher when compared to healthy 
people, some reports claim that there were not any dif-
ferences (6,9-11).
Lugliè et al. (9) evaluated the oral hygiene indices, S. 
mutans levels and DMTF indices of 18 TM patients 
aged between 23 and 31 years, and 18 control group pa-
tients in the same age range, in 2002. The authors stated 
that S. mutans values were significantly higher in TM 
patients when compared to control group, and, although 
the DMFT indices were higher in TM patients (TM: 
DMFT=10.3; control: DMFT=9.4), this difference was 
not significant. In addition, no statistically meaning-
ful difference in the oral hygiene indices between the 
two groups was determined while plaque existence was 
higher in the control group patients.
In the same year, Al-Wahadni et al. (10) analyzed 
DMFT, plaque and gingival index values in a study of 
61 β-TM patients and 63 control patients aged 6-12 and 
13-18-years. The results revealed that the DMTF indices 
were significantly higher in β-TM patients for both of 
the age groups. Plaque and gingival index values were 
also higher in β-TM patients, in both age groups, but it 
was not significant.  
In 2001, Hattab et al. (11) examined the plaque scores 
and DMFT/dmft values of 54 TM patients aged between 
6 and 18 years. The dmft ratio was 6.92 for 6–7-year-
olds, and 4.72 for 8–9-year-olds, and the DMFT ratio 
was 6.57 for 12–14-year-olds, and 5.95 for those in the 
15–18-year age group, respectively. No significant rela-
tionship between the patient groups during the tempo-
rary and permanent dentition periods was reported. The 
authors documented a high plaque score in 61.1% of the 
TM patients and described the patients as having poor 
oral hygiene status. 
Recently, Al-Raeesi et al. (6) comparatively assessed 
the DMFT/dmft indices, oral hygiene index, occlusal 
anomalies, dentofacial and soft-tissue abnormalities in 
a total of 38 β-TM and 76 healthy Emirati children. The 
children with β-TM had a significantly higher DMFT 
and calculus index compared to the healthy controls, but 
a significantly lower gingivitis proportion.
In our study, the S. mutans counts, and the DMFT, 
plaque and oral hygiene indices of 59 β-TM and 50 
control patients, aged between 6 and 16 years, were in-
vestigated. In accordance with Luglie et al. (9), the S. 
mutans levels in our study were significantly higher in 
the β-TM group when compared with the control group. 
The DMFT indices were significantly higher in β-TM 
patients than the control group, which concurred with 
the studies of Al-Raeesi et al. (6) and Al-Wahadmi et 
Table 3: Distribution of Streptococcus mutans, Lactobacillus values.
Streptococcus mutans Lactobacillus Total































































































(Streptococcus mutans; p=0.002, Mixed Dentition; p>0.05, Permanent Dentition; 
p=0.008) (Lactobacillus; p>0.05).
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al. (10), but the data presented by Luglie et al. (9) were 
comparatively lower. Al-Wahadmi et al. (10), stated that 
DMFT ratios increased together with age in their study. 
In the current work, the plaque and oral hygiene index 
values were statistically higher in the β-TM patients, 
contrary to the research by Luglie et al. (9) and Al-Wa-
hadmi et al. (10).  The study carried out by Hattab et al. 
(8), reported that more than half of TM patients had a 
high plaque score. The differences between these stud-
ies and our work could originate from several param-
eters, such as the preferred study methods, and regional 
and socioeconomic factors.
Lactobacillus, which is responsible for dentin decay, 
was also examined in our study and no significant 
association occurred between the β-TM and control 
groups. According to the scanning results of available 
resources, no other studies have previously explored the 
saliva Lactobacillus densities of β-TM patients. There 
is a need for extensive studies to examine salivary S. 
mutans and Lactobacillus densities of β-TM patients. 
When investigating the relationship between decay and 
gender in 47 TM patients, Leonardi et al. (18), noticed a 
higher decay prevalence in male TM patients. However, 
in Hattab et al. (11), and our study, a significant effect of 
gender was not determined.
Literature studies suggest the gingivitis occurrence fre-
quency can be higher in TM patients than healthy indi-
viduals, and this can result from local factors or oral-
maxillo-facial features of the disorder (9,11,12,19). In 
2007, Ay et al. (20), compared to the blood lipid levels 
and periodontal parameters (gingival index, plaque in-
dex, probing bleeding, probing depth) in 24 TM patients 
with 20 age-matched control patients, and found that all 
periodontal parameters were significantly higher in the 
TM patients. Siamopoulou-Mavridou et al. (12), exam-
ined the gingivitis and decay experiences, as well as the 
flow rate, calcium, phosphorous, potassium, sodium, 
urea and lysozyme immunoglobulin levels (IgA, IgG, 
IgM) of the saliva of 21 TM and 83 control patients. Ac-
cording to the results, gingivitis and decay prevalence 
were statistically higher in TM patients. No significant 
difference was found in the flow rate of saliva while 
phosphorous and IgA were significantly lower in TM 
patients.
One of the aims of our study was to assess the decay 
tendency levels, by comparing saliva buffering capaci-
ties of β-TM and control patients, and no significant 
relationship was determined. To the best of our knowl-
edge, no other current studies have analyzed the saliva 
buffering capacities of TM patients. 
Multiple immune disorders can be seen in TM patients, 
which can create a predisposing effect for oral Candida 
(21-23). Candida types are opportunistic pathogens that 
exist in normal oral flora but can cause serious infec-
tions when the immune system is weakened. Candida 
albicans is mentioned in the literature as the most iso-
lated type, both in healthy people and TM patients (21-
23).
In 2010, Hazza’a et al. (23) surveyed oral Candida 
carriers within 50 β-TM and 50 control patients by 
the mouthwash method. Candida was isolated in 74% 
(n=37) of the TM patients and 56% (n=28) of the control 
group, and the difference was significant. 
In our study, Candida was isolated in 25.4% (15 pa-
tients) of β-TM patients and 34% (17 patients) of control 
patients and, according to our results, no significant re-
lationship was evident between the study and control 
groups. Less Candida was isolated in β-TM patients 
in our study when compared with the study of Hazza’a 
et al. (23), probably due to differences in the methods 
used since Hazza’a et al. (23) preferred the mouthwash 
technique as the sample collection method, whereas, in 
our study, swab samples from the cheek and soft palate 
regions were collected. Socioeconomic, regional and 
other differences could be other factors contributing to 
the discrepancy. 
To date, there are limited numbers of studies on oral 
Candida colonization of TM patients in the literature. 
Extensive studies are required, considering the occur-
rence possibility of Candida, among TM patients ac-
companied by multiple immune disorders.
The prevalence of β-TM patients in Antalya Province 
(West Mediterranean Region of Turkey) (12–13.1%) is 
above Turkeys’ average, so regular and strict treatment/
follow-up protocols are carried out for β-TM patients 
in this region (24). This scenario allows envisaging the 
complications (e.g., oro-facial deformities, infections of 
the immune system, Candida infection) that can be ex-
perienced in β-TM patients. Educative and informative 
programs about treatment and follow-up of the disorder 
have been conducted regularly, for primary protection, 
as part of the treatment protocol.
As a conclusion, oro-dento-facial problems can be pre-
vented before they occur, providing close examination 
by a dentist at diagnosis, treatment and follow-up of TM 
patients, beginning from childhood. Especially, pediat-
ric dentists have a major preventive role in these prob-
lems. It is important that hematologists and pediatric 
dentists work together during treatment and follow-up 
procedures of TM patients. Informative and educative 
programs for TM patients and their parents must be pro-
vided by pediatric dentists, addressing complications 
which can occur in oro-dento-facial structures, as well 
as solutions and considerations. 
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